再生障碍性贫血并发慢性硬膜下血肿1例报告

2018-10-20 孙林林 付爱军 张志勇 河北联合大学学报(医学版

患者,21岁,男性。因头部外伤史2月余,突发头痛伴恶心、呕吐3天入院。入院查体:体温36.5°C,脉搏70次/min,血压130/85mmHg,呼吸18次/min。神清语利,查体合作,双侧瞳孔直径20mm光反射灵敏,颈软,无抵抗,四肢肌力V级,双侧巴氏征(+)。余查体未见明显异常。既往史:再生障碍性贫血18年,平日输注悬浮红细胞(2U、1次/3~4周)治疗,再生障碍相关贫血性心脏病史2年余。

1.病历报告
 
患者,21岁,男性。因头部外伤史2月余,突发头痛伴恶心、呕吐3天入院。入院查体:体温36.5°C,脉搏70次/min,血压130/85mmHg,呼吸18次/min。神清语利,查体合作,双侧瞳孔直径20mm光反射灵敏,颈软,无抵抗,四肢肌力V级,双侧巴氏征(+)。余查体未见明显异常。既往史:再生障碍性贫血18年,平日输注悬浮红细胞(2U、1次/3~4周)治疗,再生障碍相关贫血性心脏病史2年余。
 
实验室检查:入院血常规提示三系减少,见表1。肝功、肾功、血脂、血糖均未见明显异常。凝血四项示:活化部分凝血活酶时间(APTT)为25s,凝血酶原时间(PT)为11s,血浆纤维蛋白原(FIB)4.42g/L,凝血酶时间(TT)为13s。颅脑CT扫描(下图A)示:左侧额颞顶部慢性硬膜下血肿(血量约70mL、最大厚度约18mm)。临床诊断:慢性硬膜下血肿;再生障碍性贫血。
 
2治疗经过
 
围手术期处理:针对患者再生障碍性贫血引起难治的三系减少,据血液系统化验给予成分输血(红细胞、血小板等)对症治疗。对症治疗前后血象变化见表1。术中及术后风险评估:患者血小板(PLT)减少可能引起出血,白细胞(WBC)减少可能感染、贫血性心脏疾病等风险。
 
表1  患者不同时间的血象 


考虑到患者头痛症状加重,头颅CT提示具有手术指征。在全麻下行钻单孔引流术引出酱油色陈旧性不凝血。术中严密止血,静滴头孢曲松预防术后出血、感染等。术后患者头痛症状好转,术后3天无头痛症状。共住院15天痊愈出院。随访3个月良好。
 
患者颅脑CT扫描提示如下图:A(入院第1天):血肿高低混杂密度影,占位效应明显,左侧脑室受压明显,中线移位;B(入院第6天术前3h):血肿呈等密度影,脑沟回变浅;C(入院后第9天术后3天):血肿明显减少,脑沟回恢复。
 
 
原始出处:

孙林林, 付爱军, 张志勇,等. 再生障碍性贫血并发慢性硬膜下血肿1例报告[J]. 河北联合大学学报(医学版), 2017, 19(2):158-159.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2054155, encodeId=ea6b2054155fc, content=<a href='/topic/show?id=39e8e362693' target=_blank style='color:#2F92EE;'>#硬膜下#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73626, encryptionId=39e8e362693, topicName=硬膜下)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6142500060, createdName=12498710m11暂无昵称, createdTime=Tue Sep 24 02:24:00 CST 2019, time=2019-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758037, encodeId=44a11e580377b, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sat Feb 23 20:24:00 CST 2019, time=2019-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1722304, encodeId=38011e22304a1, content=<a href='/topic/show?id=ee015360485' target=_blank style='color:#2F92EE;'>#慢性硬膜下血肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53604, encryptionId=ee015360485, topicName=慢性硬膜下血肿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e66c33257185, createdName=wodejia-dayu, createdTime=Sun Feb 24 19:24:00 CST 2019, time=2019-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394934, encodeId=4855139493474, content=<a href='/topic/show?id=be548989e09' target=_blank style='color:#2F92EE;'>#血肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89897, encryptionId=be548989e09, topicName=血肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85df2500173, createdName=654699882_84926986, createdTime=Mon Oct 22 01:24:00 CST 2018, time=2018-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419914, encodeId=868c141991400, content=<a href='/topic/show?id=3951e36293b' target=_blank style='color:#2F92EE;'>#硬膜下血肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73629, encryptionId=3951e36293b, topicName=硬膜下血肿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b293545002, createdName=lizhou0205, createdTime=Mon Oct 22 01:24:00 CST 2018, time=2018-10-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2054155, encodeId=ea6b2054155fc, content=<a href='/topic/show?id=39e8e362693' target=_blank style='color:#2F92EE;'>#硬膜下#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73626, encryptionId=39e8e362693, topicName=硬膜下)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6142500060, createdName=12498710m11暂无昵称, createdTime=Tue Sep 24 02:24:00 CST 2019, time=2019-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758037, encodeId=44a11e580377b, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sat Feb 23 20:24:00 CST 2019, time=2019-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1722304, encodeId=38011e22304a1, content=<a href='/topic/show?id=ee015360485' target=_blank style='color:#2F92EE;'>#慢性硬膜下血肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53604, encryptionId=ee015360485, topicName=慢性硬膜下血肿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e66c33257185, createdName=wodejia-dayu, createdTime=Sun Feb 24 19:24:00 CST 2019, time=2019-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394934, encodeId=4855139493474, content=<a href='/topic/show?id=be548989e09' target=_blank style='color:#2F92EE;'>#血肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89897, encryptionId=be548989e09, topicName=血肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85df2500173, createdName=654699882_84926986, createdTime=Mon Oct 22 01:24:00 CST 2018, time=2018-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419914, encodeId=868c141991400, content=<a href='/topic/show?id=3951e36293b' target=_blank style='color:#2F92EE;'>#硬膜下血肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73629, encryptionId=3951e36293b, topicName=硬膜下血肿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b293545002, createdName=lizhou0205, createdTime=Mon Oct 22 01:24:00 CST 2018, time=2018-10-22, status=1, ipAttribution=)]
    2019-02-23 丁鹏鹏
  3. [GetPortalCommentsPageByObjectIdResponse(id=2054155, encodeId=ea6b2054155fc, content=<a href='/topic/show?id=39e8e362693' target=_blank style='color:#2F92EE;'>#硬膜下#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73626, encryptionId=39e8e362693, topicName=硬膜下)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6142500060, createdName=12498710m11暂无昵称, createdTime=Tue Sep 24 02:24:00 CST 2019, time=2019-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758037, encodeId=44a11e580377b, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sat Feb 23 20:24:00 CST 2019, time=2019-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1722304, encodeId=38011e22304a1, content=<a href='/topic/show?id=ee015360485' target=_blank style='color:#2F92EE;'>#慢性硬膜下血肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53604, encryptionId=ee015360485, topicName=慢性硬膜下血肿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e66c33257185, createdName=wodejia-dayu, createdTime=Sun Feb 24 19:24:00 CST 2019, time=2019-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394934, encodeId=4855139493474, content=<a href='/topic/show?id=be548989e09' target=_blank style='color:#2F92EE;'>#血肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89897, encryptionId=be548989e09, topicName=血肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85df2500173, createdName=654699882_84926986, createdTime=Mon Oct 22 01:24:00 CST 2018, time=2018-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419914, encodeId=868c141991400, content=<a href='/topic/show?id=3951e36293b' target=_blank style='color:#2F92EE;'>#硬膜下血肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73629, encryptionId=3951e36293b, topicName=硬膜下血肿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b293545002, createdName=lizhou0205, createdTime=Mon Oct 22 01:24:00 CST 2018, time=2018-10-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2054155, encodeId=ea6b2054155fc, content=<a href='/topic/show?id=39e8e362693' target=_blank style='color:#2F92EE;'>#硬膜下#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73626, encryptionId=39e8e362693, topicName=硬膜下)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6142500060, createdName=12498710m11暂无昵称, createdTime=Tue Sep 24 02:24:00 CST 2019, time=2019-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758037, encodeId=44a11e580377b, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sat Feb 23 20:24:00 CST 2019, time=2019-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1722304, encodeId=38011e22304a1, content=<a href='/topic/show?id=ee015360485' target=_blank style='color:#2F92EE;'>#慢性硬膜下血肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53604, encryptionId=ee015360485, topicName=慢性硬膜下血肿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e66c33257185, createdName=wodejia-dayu, createdTime=Sun Feb 24 19:24:00 CST 2019, time=2019-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394934, encodeId=4855139493474, content=<a href='/topic/show?id=be548989e09' target=_blank style='color:#2F92EE;'>#血肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89897, encryptionId=be548989e09, topicName=血肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85df2500173, createdName=654699882_84926986, createdTime=Mon Oct 22 01:24:00 CST 2018, time=2018-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419914, encodeId=868c141991400, content=<a href='/topic/show?id=3951e36293b' target=_blank style='color:#2F92EE;'>#硬膜下血肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73629, encryptionId=3951e36293b, topicName=硬膜下血肿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b293545002, createdName=lizhou0205, createdTime=Mon Oct 22 01:24:00 CST 2018, time=2018-10-22, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2054155, encodeId=ea6b2054155fc, content=<a href='/topic/show?id=39e8e362693' target=_blank style='color:#2F92EE;'>#硬膜下#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73626, encryptionId=39e8e362693, topicName=硬膜下)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6142500060, createdName=12498710m11暂无昵称, createdTime=Tue Sep 24 02:24:00 CST 2019, time=2019-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758037, encodeId=44a11e580377b, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sat Feb 23 20:24:00 CST 2019, time=2019-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1722304, encodeId=38011e22304a1, content=<a href='/topic/show?id=ee015360485' target=_blank style='color:#2F92EE;'>#慢性硬膜下血肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53604, encryptionId=ee015360485, topicName=慢性硬膜下血肿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e66c33257185, createdName=wodejia-dayu, createdTime=Sun Feb 24 19:24:00 CST 2019, time=2019-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394934, encodeId=4855139493474, content=<a href='/topic/show?id=be548989e09' target=_blank style='color:#2F92EE;'>#血肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89897, encryptionId=be548989e09, topicName=血肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85df2500173, createdName=654699882_84926986, createdTime=Mon Oct 22 01:24:00 CST 2018, time=2018-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419914, encodeId=868c141991400, content=<a href='/topic/show?id=3951e36293b' target=_blank style='color:#2F92EE;'>#硬膜下血肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73629, encryptionId=3951e36293b, topicName=硬膜下血肿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b293545002, createdName=lizhou0205, createdTime=Mon Oct 22 01:24:00 CST 2018, time=2018-10-22, status=1, ipAttribution=)]

相关资讯

重症系统性红斑狼疮合并纯红细胞再生障碍性贫血1例

患者男性,新兵战士,19岁,2015年6月3日始无明显诱因出现乏力、间断流鼻血,当时无明显发热,无尿频、尿急、尿痛及肉眼血尿,未予重视